[OncoHost in The Times of Israel] Israel’s OncoHost, UK’s NHS to study cancer patient responses to immunotherapies

Israel-based startup OncoHost, the developer of a blood test to predict how well cancer patients will react to treatment, said it will collaborate with the National Health Service (NHS) to set up eight clinical trial sites in the United Kingdom.

Read more here.